Exagen Inc. XGN

Set alert

Price alert · XGN

All alert types
8.39 USD -0.20 -2.33%

At close · Nov 2

8.39 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
8.36 × 2
Ask
8.40 × 2
8.21 Day range 8.67
2.59 52-week range 11.92
YTD
+37.99%
1 year
-28.11%
Open
8.59
Prev close
8.59
Mkt cap
203.25M
Vol
243.09K
Avg vol
370.26K
EPS
-0.81
P/E
0.00
Div yield
0.00%
More statistics
Low
8.21
High
8.67
Forward P/E
-5.96
Beta
1.35
Short ratio
3.12
Inst. own
57.22%
Dividend
0.00
Ex-div date
Earnings
Aug 5, 2024
50-d avg
3.59
200-d avg
2.50
1y target
6.25

MAX chart

Chart tools
Interval

Events in this range
  • Nov 17, 2022Rating: BTIG · — → Buy
  • Mar 22, 2023Rating: BTIG · — → Buy
  • May 16, 2023Rating: Cantor Fitzgerald · Overweight → Overweight
  • Aug 22, 2023Rating: Cantor Fitzgerald · Overweight → Overweight
  • Sep 26, 2023Rating: Cantor Fitzgerald · Overweight → Overweight
  • Mar 18, 2024Earnings: -0.31; estimate -0.41; surprise 24.39%
  • May 13, 2024Earnings: —; estimate -0.4; surprise —%
  • May 13, 2024Earnings: -0.19; estimate -0.4; surprise 52.5%
  • May 14, 2024Rating: Cantor Fitzgerald · Overweight → Overweight
  • Aug 5, 2024Earnings: -0.16; estimate -0.36; surprise 55.56%
  • Aug 5, 2024Earnings: —; estimate -0.36; surprise —%
  • Nov 12, 2024Earnings: -0.28; estimate -0.3; surprise 6.67%
Signals (112)
NameDateAgo
SMA: BullishOct 26, 20261 week ago
SMA: BearishOct 12, 20263 weeks ago
RSI: OverboughtSep 21, 20261 month ago
RSI: OverboughtAug 17, 20262 months ago
SMA: BullishAug 3, 20263 months ago
SMA: BearishJul 27, 20263 months ago
SMA: BullishJul 20, 20263 months ago
SMA: BearishJul 13, 20263 months ago
SMA: BullishJun 8, 20264 months ago
SMA: BearishJun 1, 20265 months ago
SMA: BullishMay 25, 20265 months ago
SMA: BullishMay 11, 20265 months ago
SMA: BearishMay 4, 20266 months ago
SMA: BullishApr 27, 20266 months ago
MACD: Buy SignalApr 27, 20266 months ago
RSI: OversoldJan 12, 20269 months ago
SMA: BearishNov 17, 202511 months ago
SMA: BearishNov 3, 20251 year ago
MACD: Sell SignalNov 3, 20251 year ago
RSI: OverboughtJul 28, 20251 year ago

Newest 20 of 112.

Analyst view

Consensus: none

Price target (mean) 6.25 -25.5% downside
Target (low)
5.00
Target (mean)
6.25
Target (high)
8.00
Ratings (0m) 6 5 buy · 1 hold · 0 sell
  • Strong buy0
  • Buy5
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 6

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

XGN analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.2425-0.30 – -0.10-0.31+21.8%13.53M-1.7%4
Next quarter-0.24-0.27 – -0.20-0.19-26.3%14.66M+1.7%3
Current year-0.905-0.93 – -0.86-1.34+32.5%55.53M+5.7%4
Next year-0.72-0.82 – -0.56-0.905+20.4%65.15M+17.3%4

Upgrades and downgrades

The latest rating changes

XGN analyst upgrades and downgrades
DateFirmActionFromTo
May 14, 2024Cantor FitzgeraldMaintainedOverweightOverweight
Sep 26, 2023Cantor FitzgeraldReiteratedOverweightOverweight
Aug 22, 2023Cantor FitzgeraldReiteratedOverweightOverweight
May 16, 2023Cantor FitzgeraldReiteratedOverweightOverweight
Mar 22, 2023BTIGMaintained—Buy
Nov 17, 2022BTIGMaintained—Buy
Nov 15, 2022Canaccord GenuityMaintained—Buy
May 13, 2022KeybancMaintained—Overweight
Mar 25, 2022KeybancMaintained—Overweight
Nov 11, 2021KeybancMaintained—Overweight
Apr 15, 2021Canaccord GenuityInitiated—Buy
Mar 2, 2021KeybancMaintained—Overweight
Nov 10, 2020KeybancInitiated—Overweight
Oct 8, 2020BTIGInitiated—Buy
Nov 13, 2019Cantor FitzgeraldMaintained—Overweight
Oct 14, 2019Cantor FitzgeraldInitiated—Overweight
Oct 14, 2019Cowen & Co.Initiated—Outperform
Oct 14, 2019William BlairInitiated—Outperform